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ABSTRACT
Over the latest years the occurrence of pharmaceutical residues in the environment has been
motivating an increasing concern over the possible harmful effects of many of these pollutants
to living organisms. In fact  many reports are available in the literature about the detection of
several of the most consumed pharmaceuticals, their metabolites and transformation products in
wastewaters as well as surface and ground waters and even in drinking waters worldwide. This
situation can be attributed to the general inadequacy of the conventional treatment processes
used in wastewater treatment plants (WWTPs) in dealing with trace pollutants.
The reason for the low efficiencies of conventional WWTPs for removal of pharmaceuticals is
the fact  that  these plants were designed to remove bulk constituents of wastewater such as
suspended solids, dissolved biodegradable organic matter, pathogens and nutrients and not for
also dealing with trace pollutants in general. Due to the highly variable physical and chemical
properties of these organic compounds, the efficiencies by which they are removed may vary
substantially. 
Despite  the  low concentration levels  at  which  pharmaceuticals  are  generally  present  in  the
environment, there is a significant potential for synergistic effects between compounds with
similar modes of action or related therapeutic targets, which is enough to be of serious concern.
Therefore,  there  is  an urgent  need to  find ways of  retaining and removing these pollutants
before they reach the receiving water bodies. Optimization of the WWTP processes has been
tried by increasing hydraulic and solid retention times, for example. In addition, some advanced
technologies  have  been  evaluated  to  decrease  their  discharge  into  water  bodies.  However,
despite the sometimes high removal efficiencies attained, these processes are generally not cost-
effective on a large scale. In fact, it remains a crucial necessity to find applicable technologies
for removing pharmaceuticals from wastewater with higher efficiencies at reasonable cost of
operation and maintenance.
Constructed  wetlands  systems  (CWS)  are  being  increasingly  used  as  an  option  to  remove
micropollutants, in particular organic xenobiotic compounds, from wastewaters. There is a vast
range of studies highlighting the high efficiencies of these systems in removing a wide variety
of compound types, including some pharmaceuticals. For this reason, this type of systems are
being adopted as a tertiary treatment option in domestic wastewater treatment and, also, at least
as part of the specialized wastewater treatment plants of some industries (such as chemical, dye,
tannery, livestock, etc.).
Often CWS have been studied under a “black box” approach where only influent and effluent
pollutants concentrations were assessed and no further in-depth investigations were pursued.
However, in order to use CWS as a more efficient response to new challenges such as those
presented by the more recalcitrant micropollutants, a thorough characterization of the processes
involved in pollutants removal in CWS is direly needed, as well as some understanding of the
ways the several CWS components (solid matrix, vegetation and microorganisms) may interact
with each other synergistically. This, in fact, has been an effort which increasingly has been
undertaken in the most recent years as a new trend in CWS research, not only in field studies
but also in numerous lab studies as well. As result of the increases knowledge of such processes
and interactions, a better guidance in the selection and optimization of the CWS components for
more specific applications becomes possible.
In this  work  we  intend  to  present  a  review  of  the  main  pharmaceutical  removal  and
transformation processes in CWS, the roles played by the most important components of CWS
in such processes and how the overall treatment system performance is affected by all these.
Some attention will be given to the most recent studies published on this subject, especially
those involving specific CWS application for the removal of pharmaceuticals and which focus
on the characterization/optimization of processes or the selection of CWS components. Some of
the questions remaining to be addressed about the removal mechanisms in CWS and the aspects
of CWS operation that still require optimization will also be highlighted in this work.
